Method for increasing concentration of avenanthramides in oats

Details for Australian Patent Application No. 2010228083 (hide)

Owner Her Majesty the Queen in Right of Canada as represented by The Minister of Agriculture and Agri-Food

Inventors Collins, Frank William; Burrows, Vernon Douglas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010228083

PCT Pub. Number WO2010/108277

Priority 61/163,975 27.03.09 US

Filing date 25 March 2010

Wipo publication date 30 September 2010

International Classifications

C12P 13/02 (2006.01) Preparation of nitrogen-containing organic compounds

A23K 1/16 (2006.01) Animal feeding-stuffs - supplemented with accessory food factors

A23L 1/10 (2006.01) Foods or foodstuffs - containing cereal-derived products

A23L 1/168 (2006.01) Foods or foodstuffs - Cereal granules or flakes to be cooked and eaten hot, e.g. oatmeal

A61K 31/196 (2006.01)

A61K 36/899 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

B02C 9/00 (2006.01) Other milling methods or mills specially adapted for grain

C12C 1/047 (2006.01) Preparation of malt

C12P 1/00 (2006.01) Preparation of compounds or compositions, not provided for in groups , by using micro-organisms or enzymes

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/108277 Priority application(s): WO2010/108277

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010228091-Non-braided reinforced hollow fibre membrane

2010228068-Tissue kallikrein for the treatment of pancreatic beta-cell dysfunction